Molecular Partners AG
SIX:MOLN
Molecular Partners AG
Cash from Investing Activities
Molecular Partners AG
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Molecular Partners AG
SIX:MOLN
|
Cash from Investing Activities
CHf44.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Cash from Investing Activities
-$3.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Cash from Investing Activities
$374.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Cash from Investing Activities
-CHf1m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
30%
|
|
Idorsia Ltd
SIX:IDIA
|
Cash from Investing Activities
CHf743.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Cash from Investing Activities
-CHf326k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
See Also
What is Molecular Partners AG's Cash from Investing Activities?
Cash from Investing Activities
44.6m
CHF
Based on the financial report for Dec 31, 2023, Molecular Partners AG's Cash from Investing Activities amounts to 44.6m CHF.